Grace Therapeutics GRCE
NASDAQ GRCE
$2.18 +0.04 (+2.06%)
As of: Aug 21, 2026 · 12:30 PM EDT

Grace Therapeutics (GRCE) EBT Margin (QoQ) (2021)

Grace Therapeutics (GRCE) EBT Margin (QoQ) (2021) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.57 Bn 131.72 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.71 Bn 78.72 Bn 3.93 Bn
3 Argenx Se 65.44 Bn 60.25 Bn 1.37 Bn
4 Moderna 60.06 Bn 54.93 Bn 52.00 Mn
5 BeOne Medicines 42.16 Bn 37.06 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.89 Bn 28.58 Bn 992.69 Mn
7 BioNTech SE 28.11 Bn 9.72 Bn 668.28 Mn
8 Insmed 27.59 Bn 26.43 Bn 358.27 Mn
9 Royalty Pharma 27.33 Bn 26.49 Bn -
10 Grace Therapeutics 37.72 Mn 37.72 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2021 30,300.00